Daily Archives: October 22, 2020
Best practices in managing cardiac arrest in the emergency department during the COVID-19 pandemic
22 Oct, 2020 | 09:44h | UTC
Amid pandemic, U.S. has seen 300,000 ‘excess deaths,’ with highest rates among people of color
22 Oct, 2020 | 09:41h | UTC
Commentary on Twitter
A new @CDCMMWR estimates since January 2020, 299,000 more people have died than the typical number during the same weeks in previous years. At least 2 out of 3 excess deaths were attributed to #COVID19. Learn more: https://t.co/fg4W6u4e3C. pic.twitter.com/i9TDxrBrTV
— CDC (@CDCgov) October 20, 2020
Randomized trial: Tocilizumab does not improve outcomes for patients hospitalized with Covid-19
22 Oct, 2020 | 09:42h | UTCEfficacy of Tocilizumab in Patients Hospitalized with Covid-19 – New England Journal of Medicine
New 2020 AHA Guidelines for CPR and emergency cardiovascular care in adults and children
22 Oct, 2020 | 09:47h | UTCHighlights: 2020 AHA Guidelines Update for CPR and ECC
Executive Summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care
New calculator predicts risk of hospital admission and mortality from coronavirus 19 in adults
22 Oct, 2020 | 09:37h | UTCSee calculator: QCovid® risk calculator
Commentary on Twitter
A new "living" high quality prediction model for #COVID19 risk for hospitalization and mortality: top 20% risk accounted for 94% of deaths; https://t.co/aPXRM2pHCq calculatorhttps://t.co/gdd8b3j33K @bmj_latest
by @AshClift @JuliaHCox @OxPrimaryCare and colleagues pic.twitter.com/s8TrWWECb0— Eric Topol (@EricTopol) October 21, 2020
SARS-CoV-2 immunity: Review and applications to phase 3 vaccine candidates
22 Oct, 2020 | 09:36h | UTCSARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates – The Lancet
Commentary: The COVID-19 vaccine pipeline – News Medical
Commentary on Twitter
NEW Review—G Poland, I Ovsyannikova & R Kennedy @MayoClinic discuss what is currently known about human humoral & cellular immune responses to SARS-CoV-2 & relate this knowledge to the #COVID19 vaccines currently in phase 3 clinical trials https://t.co/eDkFq4WStA pic.twitter.com/hfw6yjviym
— The Lancet (@TheLancet) October 14, 2020
Will Covid-19 vaccines save lives? Current trials aren’t designed to tell us
22 Oct, 2020 | 09:40h | UTCWill covid-19 vaccines save lives? Current trials aren’t designed to tell us – The BMJ
Commentaries: COVID-19 vaccine trials won’t tell us if the shots save lives, expert notes – CNN AND Coronavirus vaccine trials won’t tell us if they save lives, prevent serious illness or stop transmission – here’s why – The Conversation
Commentary on Twitter
The world is waiting on a vaccine for covid-19 that will reduce the likelihood of getting severely ill and prevent infection. Yet the current phase III trials are not actually set up to prove either, finds Peter Doshi https://t.co/BSb9WiUQXo
— The BMJ (@bmj_latest) October 21, 2020
Meta-analysis: Efficacy and safety of tranexamic acid in acute traumatic brain injury
22 Oct, 2020 | 09:31h | UTC
Commentary on Twitter
Tranexamic acid in acute TBI
➡️ 9 RCTs/14,747 pts
➡️ probably NO effect on mortality or disability
➡️ may decrease hematoma expansion on subsequent imaging (likely of minor importance to pts)
➡️ probably NO increased risk of adverse events#FOAMcc @yourICM https://t.co/sqn80NfNv4 pic.twitter.com/dMf8rYowC2— Intens Care Med (@yourICM) October 21, 2020
Study: COVID-19 mitigation measures linked to lower incidence of preterm birth
22 Oct, 2020 | 09:35h | UTCCommentary: Did Lockdowns Lower Premature Births? A New Study Adds Evidence – The New York Times
Meta-analysis: Dual antiplatelet therapy after percutaneous coronary intervention and drug-eluting stents
22 Oct, 2020 | 09:29h | UTC
Perspective: Immunity and Re-Infection
22 Oct, 2020 | 09:34h | UTCImmunity and Re-Infection – Science Translational Medicine
Imaging features and differential diagnoses of non-neoplastic diffuse mediastinal diseases
22 Oct, 2020 | 09:26h | UTC
Professionalism revealed: Rethinking quality improvement in the wake of a pandemic
22 Oct, 2020 | 09:32h | UTCProfessionalism Revealed: Rethinking Quality Improvement in the Wake of a Pandemic – NEJM Catalyst
ATS Conference coverage: Many patients prescribed home oxygen after an acute COPD exacerbation no longer meet the criteria two to three months later
22 Oct, 2020 | 09:25h | UTCBreathing easier from hospital to home – ACP Internist
Meta-analysis: Evaluating prophylactic heparin in ambulatory patients with solid tumors
22 Oct, 2020 | 09:23h | UTCEvaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis – The Lancet Haematology (free registration required)